REGiMMUNE Limited and Kiji Therapeutics Officially End Potential Merger
Taipei, 27 March 2025 – REGiMMUNE Limited, a biotech company [...]
Taipei, 27 March 2025 – REGiMMUNE Limited, a biotech company [...]
The intended merger will create a pan-global Treg specialist to [...]
TAIPEI, June 4, 2024 – REGiMMUNE Limited is pleased to [...]
TAIPEI, May 6, 2024 – REGiMMUNE Limited, a clinical-stage biopharmaceutical [...]
TAIPEI, April 11, 2024 – REGiMMUNE Limited, a clinical-stage biopharmaceutical [...]
TAIPEI, February 22, 2024 – REGiMMUNE Limited, a clinical-stage biopharmaceutical [...]
TAIPEI, December 28, 2023 – REGiMMUNE Limited, a clinical-stage biopharmaceutical [...]
Taipei, July 6, 2023 – REGiMMUNE Limited (REGiMMUNE), a biotech [...]
Taipei, March 29, 2023 – REGiMMUNE Limited (REGiMMUNE), a biotech [...]
RGI-2001 was well tolerated and associated with a meaningful reduction [...]